SupplementsPodcast Summary

Dr. Charles Brenner Reveals Which NAD Boosters Actually Work for Anti-Aging

Leading NAD researcher cuts through supplement hype to reveal what actually raises NAD levels and fights inflammation in humans.

Saturday, March 28, 2026 0 views
Published in FoundMyFitness
Podcast visualization: Dr. Charles Brenner Reveals Which NAD Boosters Actually Work for Anti-Aging

Summary

Dr. Charles Brenner, a leading NAD researcher, separates fact from fiction in the crowded world of NAD-boosting supplements. He explains how disease states, obesity, and poor sleep drain NAD levels, while clarifying which interventions actually work. Brenner discusses the human data behind nicotinamide riboside (NR) for reducing inflammation and improving recovery, while debunking popular but ineffective options like oral NAD pills and IV drips. The conversation covers practical topics including optimal dosing, timing, safety considerations, and whether healthy individuals should supplement. Brenner also explains NAD's crucial role in DNA repair and why NAD shortages particularly impact brain function, providing science-based guidance for those seeking evidence-backed longevity interventions.

Detailed Summary

This episode features Dr. Charles Brenner, a pioneering NAD researcher, who provides crucial clarity on NAD supplementation for longevity and health optimization. The discussion matters because NAD levels decline with age and disease, yet the supplement market is flooded with unproven products making bold claims without human data to support them.

Brenner explains how various factors deplete NAD levels, including viral infections like COVID-19, obesity, insulin resistance, and potentially poor sleep. He details the anti-inflammatory effects of nicotinamide riboside (NR) and its potential benefits for exercise recovery, cognitive function, and metabolic health. The conversation covers practical applications including fertility support, shift work recovery, and optimal timing for supplementation.

Key insights include why oral NAD supplements don't actually raise NAD levels, why IV NAD drips are largely hype, and how NR compares to NMN in terms of effectiveness. Brenner discusses the gut microbiome's role in NAD production and addresses safety concerns, including cancer risk and pregnancy considerations. He also explains NAD's fundamental role in DNA repair and gene regulation, particularly its importance for brain health.

Actionable takeaways include specific dosing recommendations for NR, timing strategies, and guidance on supplement sourcing quality. However, Brenner emphasizes that healthy individuals may not need supplementation, and that lifestyle factors like exercise and proper nutrition remain foundational. The episode provides evidence-based guidance for those considering NAD precursors while highlighting the need for more human research in this rapidly evolving field.

Key Findings

  • Oral NAD supplements don't raise NAD levels; nicotinamide riboside (NR) is the most effective oral precursor
  • NAD IV drips provide minimal benefit compared to oral NR supplementation
  • Disease states like COVID-19, obesity, and insulin resistance significantly deplete NAD levels
  • NR shows anti-inflammatory effects and may improve exercise recovery in human studies
  • Healthy individuals may not need NAD supplementation; lifestyle factors remain most important

Methodology

This is an interview-format podcast episode featuring Dr. Charles Brenner, a leading NAD researcher and expert in nicotinamide riboside. The discussion covers both mechanistic explanations and human clinical data, providing scientific context for NAD supplementation recommendations.

Study Limitations

Information is based on a podcast discussion rather than peer-reviewed publication. Some recommendations may reflect expert opinion rather than definitive clinical evidence. Listeners should verify specific claims with primary research sources before making supplementation decisions.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.